Evidence map›Paper›PMID 25755697›Full record

ArticleInternational journal of clinical and experimental pathology2015

Bone marrow-derived mesenchymal stem cells inhibits hepatocyte apoptosis after acute liver injury.

Yijing Cai, Zhuolin Zou, Liyuan Liu, Si Chen, Yi Chen, Zhuo Lin, Keqing Shi, Lanman Xu, Yongping Chen

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Synergistic effects ofAmerican journal of translational research · 2019
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Can glypican-3 be a disease-specific biomarker?Clinical and translational medicine · 2017
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yijing CaiDepartment of Infection Diseases, The First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang 325000, P.R. China ; Wenzhou Key Laboratory of Hepatology Wenzhou, Zhejiang 325000, P.R. China ; Hepatology Institute of Wenzhou Medical University Wenzhou, Zhejiang 325000, P.R. China.
Zhuolin ZouDepartment of Infection Diseases, The First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang 325000, P.R. China ; Wenzhou Key Laboratory of Hepatology Wenzhou, Zhejiang 325000, P.R. China ; Hepatology Institute of Wenzhou Medical University Wenzhou, Zhejiang 325000, P.R. China.
Liyuan LiuDepartment of Infection Diseases, The First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang 325000, P.R. China ; Wenzhou Key Laboratory of Hepatology Wenzhou, Zhejiang 325000, P.R. China ; Hepatology Institute of Wenzhou Medical University Wenzhou, Zhejiang 325000, P.R. China.
Si ChenDepartment of Infection Diseases, The First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang 325000, P.R. China ; Wenzhou Key Laboratory of Hepatology Wenzhou, Zhejiang 325000, P.R. China ; Hepatology Institute of Wenzhou Medical University Wenzhou, Zhejiang 325000, P.R. China.
Yi ChenDepartment of Infection Diseases, The First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang 325000, P.R. China ; Wenzhou Key Laboratory of Hepatology Wenzhou, Zhejiang 325000, P.R. China ; Hepatology Institute of Wenzhou Medical University Wenzhou, Zhejiang 325000, P.R. China.
Zhuo LinWenzhou Key Laboratory of Hepatology Wenzhou, Zhejiang 325000, P.R. China ; Hepatology Institute of Wenzhou Medical University Wenzhou, Zhejiang 325000, P.R. China.
Keqing ShiDepartment of Infection Diseases, The First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang 325000, P.R. China.
Lanman XuDepartment of Infection Diseases, The First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang 325000, P.R. China.
Yongping ChenDepartment of Infection Diseases, The First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang 325000, P.R. China ; Wenzhou Key Laboratory of Hepatology Wenzhou, Zhejiang 325000, P.R. China ; Hepatology Institute of Wenzhou Medical University Wenzhou, Zhejiang 325000, P.R. China.
Wenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the protective effect of bone marrow-derived mesenchymal stem cells (BMSCs) transplantation on acute liver injury (ALI) rats. MATERIAL AND

methodsBMSCs were extracted from rat bone marrow, cultured and expansion in vitro, and identified by flow cytometer. Rat model with acute liver injury was established by employing D-galactosamine and Lipopolysaccharide. Male rats were randomly divided into ALI model group and BMSCs transplantation group. Rats were sacrificed 24 h, 72 h and 120 h after BMSCs injection to determine alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in serum. Proliferating cell nuclear antigen (PCNA) immunohistochemistry staining and quantitative reverse transcription polymerase chain reaction (RT-PCR) of α-fetoprotein (AFP) and glypican-3 (GPC3) were performed to analysis proliferation. Terminal deoxynucleontidyl Transferase Biotin-dUTP Nick End Labeling (TUNEL) assays were used to analyze apoptosis and mitochondria-dependent-pathway related factors Bax and Bcl-2 were examined by Western blot.

resultsCompared with the ALI model group, the BMSCs transplantation group presented the lower levels of ALT, AST, decreased Bax proteins expression, and increased Bcl-2 expression. The mRNA levels of AFP and GPC3 and expression of PCNA were significantly higher in BMSCs transplantation group.

conclusionsBMSCs transplantation could significantly restore liver function. These effects were supposed to be mediated by suppressing hepatocyte apoptosis as well as promoting proliferation. Reduction of apoptosis seemed to correlate with mitochondria-dependent-pathway.

Indexed as

AnimalsApoptosisBlotting, WesternDisease Models, AnimalHepatocytesImmunohistochemistryIn Situ Nick-End LabelingLiver Failure, AcuteLiver Function TestsMaleMesenchymal Stem Cell TransplantationRatsRats, Sprague-DawleyReverse Transcriptase Polymerase Chain Reactionacute liver injuryapoptosisBone marrow-derived mesenchymal stem cells

Identifiers

PMID25755697
PMCPMC4348892
OpenAlexW41967097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.